BIOMAT Database Logo BIOMAT Database Logo

Synthesis and in vitro anti-Helicobacter pylori activity of N-[5-(5-nitro-2-heteroaryl)-1,3,4-thiadiazol-2-yl]thiomorpholines and related compounds. 2008

Javad Mirzaei, and Farideh Siavoshi, and Saeed Emami, and Fatemeh Safari, and Mohammad Reza Khoshayand, and Abbas Shafiee, and Alireza Foroumadi
School of Chemistry, University College of Science, University of Tehran, Tehran, Iran.

Synthesis and in vitro anti-Helicobacter pylori activity of N-[5-(5-nitro-2-heteroaryl)-1,3,4-thiadiazol-2-yl]thiomorpholines 5-7(a-c) and some related compounds 8a-c and 9a-c were described. The anti-H. pylori activity of target compounds along with commercially available antibiotics such as metronidazole and amoxicillin was evaluated by comparing the inhibition zone diameters determined by the paper disc diffusion bioassay. From our bioassay results against 20 clinical isolates, it is evident that most compounds still had strong activity at 4 and 2 microg/disc (average of inhibition zone >20 mm) while metronidazole had little activity at these doses. Nitrofuran analog 7b containing thiomorpholine S,S-dioxide moiety was the most potent compound tested.

UI MeSH Term Description Entries
D009025 Morpholines Tetrahydro-1,4-Oxazines,Tetrahydro 1,4 Oxazines
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000998 Antiviral Agents Agents used in the prophylaxis or therapy of VIRUS DISEASES. Some of the ways they may act include preventing viral replication by inhibiting viral DNA polymerase; binding to specific cell-surface receptors and inhibiting viral penetration or uncoating; inhibiting viral protein synthesis; or blocking late stages of virus assembly. Antiviral,Antiviral Agent,Antiviral Drug,Antivirals,Antiviral Drugs,Agent, Antiviral,Agents, Antiviral,Drug, Antiviral,Drugs, Antiviral
D013329 Structure-Activity Relationship The relationship between the chemical structure of a compound and its biological or pharmacological activity. Compounds are often classed together because they have structural characteristics in common including shape, size, stereochemical arrangement, and distribution of functional groups. Relationship, Structure-Activity,Relationships, Structure-Activity,Structure Activity Relationship,Structure-Activity Relationships
D013830 Thiadiazoles Heterocyclic compounds composed of a five-membered heterocyclic ring which contains one sulfur and two nitrogen atoms. Thiadiazole
D015394 Molecular Structure The location of the atoms, groups or ions relative to one another in a molecule, as well as the number, type and location of covalent bonds. Structure, Molecular,Molecular Structures,Structures, Molecular
D016480 Helicobacter pylori A spiral bacterium active as a human gastric pathogen. It is a gram-negative, urease-positive, curved or slightly spiral organism initially isolated in 1982 from patients with lesions of gastritis or peptic ulcers in Western Australia. Helicobacter pylori was originally classified in the genus CAMPYLOBACTER, but RNA sequencing, cellular fatty acid profiles, growth patterns, and other taxonomic characteristics indicate that the micro-organism should be included in the genus HELICOBACTER. It has been officially transferred to Helicobacter gen. nov. (see Int J Syst Bacteriol 1989 Oct;39(4):297-405). Campylobacter pylori,Campylobacter pylori subsp. pylori,Campylobacter pyloridis,Helicobacter nemestrinae
D017672 Nitrogen Compounds Inorganic compounds that contain nitrogen as an integral part of the molecule. Compounds, Nitrogen

Related Publications

Javad Mirzaei, and Farideh Siavoshi, and Saeed Emami, and Fatemeh Safari, and Mohammad Reza Khoshayand, and Abbas Shafiee, and Alireza Foroumadi
Synthesis and in vitro anti-leishmanial activity of 1-[5-(5-nitrofuran-2-yl)-1,3,4-thiadiazol-2-yl]- and 1-[5-(5-nitrothiophen-2-yl)-1,3,4-thiadiazol-2-yl]-4-aroylpiperazines.
April 2008, Bioorganic & medicinal chemistry,
Javad Mirzaei, and Farideh Siavoshi, and Saeed Emami, and Fatemeh Safari, and Mohammad Reza Khoshayand, and Abbas Shafiee, and Alireza Foroumadi
Synthesis and antibacterial activity of N-(5-benzylthio-1,3,4-thiadiazol-2-yl) and N-(5-benzylsulfonyl-1,3,4-thiadiazol-2-yl)piperazinyl quinolone derivatives.
October 2005, Bioorganic & medicinal chemistry letters,
Javad Mirzaei, and Farideh Siavoshi, and Saeed Emami, and Fatemeh Safari, and Mohammad Reza Khoshayand, and Abbas Shafiee, and Alireza Foroumadi
Synthesis and antibacterial activity of N-[5-(chlorobenzylthio)-1,3,4-thiadiazol-2-yl] piperazinyl quinolone derivatives.
February 2007, Archives of pharmacal research,
Javad Mirzaei, and Farideh Siavoshi, and Saeed Emami, and Fatemeh Safari, and Mohammad Reza Khoshayand, and Abbas Shafiee, and Alireza Foroumadi
Synthesis and in vitro antibacterial activity of N-[5-(5-nitro-2-furyl)-1,3,4-thiadiazole-2-yl] piperazinyl quinolone derivatives.
June 2003, Die Pharmazie,
Javad Mirzaei, and Farideh Siavoshi, and Saeed Emami, and Fatemeh Safari, and Mohammad Reza Khoshayand, and Abbas Shafiee, and Alireza Foroumadi
Synthesis and anti-leishmanial activity of 5-(5-nitrofuran-2-yl)-1,3,4-thiadiazol-2-amines containing N-[(1-benzyl-1H-1,2,3-triazol-4-yl)methyl] moieties.
April 2012, European journal of medicinal chemistry,
Javad Mirzaei, and Farideh Siavoshi, and Saeed Emami, and Fatemeh Safari, and Mohammad Reza Khoshayand, and Abbas Shafiee, and Alireza Foroumadi
Synthesis of new 2-(5-(5-nitrofuran-2-yl)-1,3,4-thiadiazol-2-ylimino)thiazolidin-4-one derivatives as anti-MRSA and anti-H. pylori agents.
May 2022, BMC chemistry,
Javad Mirzaei, and Farideh Siavoshi, and Saeed Emami, and Fatemeh Safari, and Mohammad Reza Khoshayand, and Abbas Shafiee, and Alireza Foroumadi
Synthesis and in vitro antibacterial evaluation of N-[5-(5-nitro-2-thienyl)-1,3,4-thiadiazole-2-yl] piperazinyl quinolones.
September 2003, European journal of medicinal chemistry,
Javad Mirzaei, and Farideh Siavoshi, and Saeed Emami, and Fatemeh Safari, and Mohammad Reza Khoshayand, and Abbas Shafiee, and Alireza Foroumadi
Synthesis and In-vitro Cytotoxicity Assessment of N-(5-(Benzylthio)-1,3,4- thiadiazol-2-yl)-2-(4-(trifluoromethyl)phenyl)acetamide with Potential Anticancer Activity.
January 2013, Iranian journal of pharmaceutical research : IJPR,
Javad Mirzaei, and Farideh Siavoshi, and Saeed Emami, and Fatemeh Safari, and Mohammad Reza Khoshayand, and Abbas Shafiee, and Alireza Foroumadi
N-(5-Mercapto-1,3,4-Thiadiazol-2-yl)-2-Phenylacetamide Derivatives: Synthesis and In-vitro Cytotoxicity Evaluation as Potential Anticancer Agents.
January 2014, Iranian journal of pharmaceutical research : IJPR,
Javad Mirzaei, and Farideh Siavoshi, and Saeed Emami, and Fatemeh Safari, and Mohammad Reza Khoshayand, and Abbas Shafiee, and Alireza Foroumadi
Synthesis of new 8-(5-substituted amino-1,3,4-oxadiazol-2-yl) and 8-(5-substituted amino-1,3,4-thiadiazol-2-yl) methoxyquinolines with antibilharzial activity.
March 1984, Journal of pharmaceutical sciences,
Copied contents to your clipboard!